-1759606108777.webp&w=3840&q=75)
2025 SPS Seattle | Hodgkin Lymphoma Front Line Efficacy and Toxicity Considerations
Overview
NA
Target Audience
Pharmacists
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Grace Baek, PharmD, BCOP
Date of Release
October 5th, 2025